Related Experiment Video

Updated: Sep 23, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.3K

Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma

Doria Filipponi1,2, Marina Pagnuzzi-Boncompagni1, Gilles Pagès1,2,3

  • 1Biomedical Department, Centre Scientifique de Monaco, 98000 Monaco, Monaco.

Cancers
|May 14, 2022
PubMed
Abstract

Insights

Targeting BMP4 signaling in medulloblastoma (MB) cancer stem cells (CSCs) inhibits pluripotency and promotes differentiation. This offers a novel therapeutic strategy for pediatric brain tumors.

Area of Science:

  • Oncology
  • Pediatric Neuro-oncology
  • Cancer Stem Cell Biology

Background:

  • Medulloblastoma (MB) is a primary malignant pediatric brain tumor and a leading cause of cancer-related death in children.
  • Cancer stem cells (CSCs) contribute to MB's tumor initiation and chemoresistance, but mechanisms of CSC maintenance remain unclear.
  • Identifying and isolating MB CSCs is challenging due to the lack of universal marker signatures.

Purpose of the Study:

  • To identify signaling pathways crucial for maintaining medulloblastoma cancer stem cells.
  • To investigate the role of pluripotency regulators in MB CSC maintenance.

Main Methods:

  • Utilized tumorsphere assays to culture and propagate MB cells.
  • Employed targeted neurogenesis PCR pathway arrays to screen for active signaling pathways.
  • Investigated the function of the octamer-binding transcription factor 4 (OCT4) in CSC maintenance.

Main Results:

  • Signaling pathways regulating pluripotency were consistently induced in MB CSCs.
  • Bone morphogenetic protein 4 (BMP4) signaling was enriched in all tumorspheres, irrespective of stem cell marker profile.
  • OCT4 enhanced MB CSC maintenance by inducing BMP4 signaling; inhibition of BMP4 signaling reduced stemness and promoted differentiation.

Conclusions:

  • Interfering with BMP4 signaling impairs MB CSC pool maintenance by promoting cell differentiation.
  • Differentiation therapy targeting BMP4 signaling presents a potential innovative therapeutic approach for MB patients.
  • This research provides a foundation for developing novel treatment strategies against medulloblastoma.
Keywords:
BMP4 signaling pathwaycancer stem celldifferentiation therapy

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K